These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28842375)

  • 1. MUC1 aptamer-capped mesoporous silica nanoparticles for controlled drug delivery and radio-imaging applications.
    Pascual L; Cerqueira-Coutinho C; García-Fernández A; de Luis B; Bernardes ES; Albernaz MS; Missailidis S; Martínez-Máñez R; Santos-Oliveira R; Orzaez M; Sancenón F
    Nanomedicine; 2017 Nov; 13(8):2495-2505. PubMed ID: 28842375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles.
    Bagheri E; Alibolandi M; Abnous K; Taghdisi SM; Ramezani M
    J Mater Chem B; 2021 Feb; 9(5):1351-1363. PubMed ID: 33447840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC1 Aptamer-Capped Mesoporous Silica Nanoparticles for Navitoclax Resistance Overcoming in Triple-Negative Breast Cancer.
    Vivo-Llorca G; Candela-Noguera V; Alfonso M; García-Fernández A; Orzáez M; Sancenón F; Martínez-Máñez R
    Chemistry; 2020 Dec; 26(69):16318-16327. PubMed ID: 32735063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gated Mesoporous Silica Nanocarriers for a "Two-Step" Targeted System to Colonic Tissue.
    González-Alvarez M; Coll C; Gonzalez-Alvarez I; Giménez C; Aznar E; Martínez-Bisbal MC; Lozoya-Agulló I; Bermejo M; Martínez-Máñez R; Sancenón F
    Mol Pharm; 2017 Dec; 14(12):4442-4453. PubMed ID: 29064714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer.
    Zhuang J; Chen S; Hu Y; Yang F; Huo Q; Xie N
    Int J Nanomedicine; 2021; 16():1961-1976. PubMed ID: 33727809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
    Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
    J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with "saccharides".
    Bernardos A; Mondragon L; Aznar E; Marcos MD; Martinez-Mañez R; Sancenon F; Soto J; Barat JM; Perez-Paya E; Guillem C; Amoros P
    ACS Nano; 2010 Nov; 4(11):6353-68. PubMed ID: 20958020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional Bioconjugate for Cancer Cell-Targeted Theranostics.
    Du W; Yuan Y; Wang L; Cui Y; Wang H; Xu H; Liang G
    Bioconjug Chem; 2015 Dec; 26(12):2571-8. PubMed ID: 26580576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme-responsive intracellular-controlled release using silica mesoporous nanoparticles capped with ε-poly-L-lysine.
    Mondragón L; Mas N; Ferragud V; de la Torre C; Agostini A; Martínez-Máñez R; Sancenón F; Amorós P; Pérez-Payá E; Orzáez M
    Chemistry; 2014 Apr; 20(18):5271-81. PubMed ID: 24700694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells.
    Hanafi-Bojd MY; Moosavian Kalat SA; Taghdisi SM; Ansari L; Abnous K; Malaekeh-Nikouei B
    Drug Dev Ind Pharm; 2018 Jan; 44(1):13-18. PubMed ID: 28832225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific targeting delivery to MUC1 overexpressing tumors by albumin-chitosan nanoparticles conjugated to DNA aptamer.
    Esfandyari-Manesh M; Mohammadi A; Atyabi F; Nabavi SM; Ebrahimi SM; Shahmoradi E; Varnamkhasti BS; Ghahremani MH; Dinarvand R
    Int J Pharm; 2016 Dec; 515(1-2):607-615. PubMed ID: 27989825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyvalent mesoporous silica nanoparticle-aptamer bioconjugates target breast cancer cells.
    Li LL; Yin Q; Cheng J; Lu Y
    Adv Healthc Mater; 2012 Sep; 1(5):567-72. PubMed ID: 23184791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of nanoaptamers using a mesoporous silica model labeled with (99m)tc for cancer targeting.
    Sá LT; Pessoa C; Meira AS; da Silva MI; Missailidis S; Santos-Oliveira R
    Oncology; 2012; 82(4):213-7. PubMed ID: 22508189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smart aptamer-modified calcium carbonate nanoparticles for controlled release and targeted delivery of epirubicin and melittin into cancer cells in vitro and in vivo.
    Yazdian-Robati R; Arab A; Ramezani M; Rafatpanah H; Bahreyni A; Nabavinia MS; Abnous K; Taghdisi SM
    Drug Dev Ind Pharm; 2019 Apr; 45(4):603-610. PubMed ID: 30633594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual aptamer-functionalized silica nanoparticles for the highly sensitive detection of breast cancer.
    Jo H; Her J; Ban C
    Biosens Bioelectron; 2015 Sep; 71():129-136. PubMed ID: 25897882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
    Zhang W; Liu M; Liu A; Zhai G
    Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin-B induced controlled release from peptide-capped mesoporous silica nanoparticles.
    de la Torre C; Mondragón L; Coll C; Sancenón F; Marcos MD; Martínez-Máñez R; Amorós P; Pérez-Payá E; Orzáez M
    Chemistry; 2014 Nov; 20(47):15309-14. PubMed ID: 25303093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel MUC1 aptamer-modified PLGA-epirubicin-PβAE-antimir-21 nanocomplex platform for targeted co-delivery of anticancer agents in vitro and in vivo.
    Bahreyni A; Alibolandi M; Ramezani M; Sarafan Sadeghi A; Abnous K; Taghdisi SM
    Colloids Surf B Biointerfaces; 2019 Mar; 175():231-238. PubMed ID: 30537619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitro.
    Yu C; Hu Y; Duan J; Yuan W; Wang C; Xu H; Yang XD
    PLoS One; 2011; 6(9):e24077. PubMed ID: 21912664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new chemotherapy agent-free theranostic system composed of graphene oxide nano-complex and aptamers for treatment of cancer cells.
    Bahreyni A; Yazdian-Robati R; Hashemitabar S; Ramezani M; Ramezani P; Abnous K; Taghdisi SM
    Int J Pharm; 2017 Jun; 526(1-2):391-399. PubMed ID: 28495579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.